img

Global Prostaglandin Analogs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prostaglandin Analogs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Prostaglandin analogues are a class of drugs that bind to a prostaglandin receptor,it used to treat hypotrichosis of the eyelashes and intraocular pressure in open angle glaucoma or ocular hypertension.
Prostaglandin Analogs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prostaglandin Analogs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinic and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prostaglandin Analogs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prostaglandin Analogs key companies include Pfizer, Novartis, Merck, Allergan and Newchem S.p.A., etc. Pfizer, Novartis, Merck are top 3 players and held % share in total in 2022.
Prostaglandin Analogs can be divided into Xalatan, Travatan, Lumigan and Tafluprost, etc. Xalatan is the mainstream product in the market, accounting for % share globally in 2022.
Prostaglandin Analogs is widely used in various fields, such as Clinic, Hospital and Others,, etc. Clinic provides greatest supports to the Prostaglandin Analogs industry development. In 2022, global % share of Prostaglandin Analogs went into Clinic filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prostaglandin Analogs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Novartis
Merck
Allergan
Newchem S.p.A.
Segment by Type
Xalatan
Travatan
Lumigan
Tafluprost

Segment by Application


Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prostaglandin Analogs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Prostaglandin Analogs introduction, etc. Prostaglandin Analogs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Prostaglandin Analogs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Prostaglandin Analogs
1.1 Prostaglandin Analogs Market Overview
1.1.1 Prostaglandin Analogs Product Scope
1.1.2 Prostaglandin Analogs Market Status and Outlook
1.2 Global Prostaglandin Analogs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Prostaglandin Analogs Market Size by Region (2024-2034)
1.4 Global Prostaglandin Analogs Historic Market Size by Region (2024-2024)
1.5 Global Prostaglandin Analogs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Prostaglandin Analogs Market Size (2024-2034)
1.6.1 North America Prostaglandin Analogs Market Size (2024-2034)
1.6.2 Europe Prostaglandin Analogs Market Size (2024-2034)
1.6.3 Asia-Pacific Prostaglandin Analogs Market Size (2024-2034)
1.6.4 Latin America Prostaglandin Analogs Market Size (2024-2034)
1.6.5 Middle East & Africa Prostaglandin Analogs Market Size (2024-2034)
2 Prostaglandin Analogs Market by Type
2.1 Introduction
2.1.1 Xalatan
2.1.2 Travatan
2.1.3 Lumigan
2.1.4 Tafluprost
2.2 Global Prostaglandin Analogs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Prostaglandin Analogs Historic Market Size by Type (2024-2024)
2.2.2 Global Prostaglandin Analogs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Prostaglandin Analogs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Prostaglandin Analogs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Prostaglandin Analogs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Prostaglandin Analogs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Prostaglandin Analogs Revenue Breakdown by Type (2024-2034)
3 Prostaglandin Analogs Market Overview by Application
3.1 Introduction
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Prostaglandin Analogs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Prostaglandin Analogs Historic Market Size by Application (2024-2024)
3.2.2 Global Prostaglandin Analogs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Prostaglandin Analogs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Prostaglandin Analogs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Prostaglandin Analogs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Prostaglandin Analogs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Prostaglandin Analogs Revenue Breakdown by Application (2024-2034)
4 Prostaglandin Analogs Competition Analysis by Players
4.1 Global Prostaglandin Analogs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostaglandin Analogs as of 2022)
4.3 Date of Key Players Enter into Prostaglandin Analogs Market
4.4 Global Top Players Prostaglandin Analogs Headquarters and Area Served
4.5 Key Players Prostaglandin Analogs Product Solution and Service
4.6 Competitive Status
4.6.1 Prostaglandin Analogs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Prostaglandin Analogs Products, Services and Solutions
5.1.4 Pfizer Prostaglandin Analogs Revenue (US$ Million) & (2024-2024)
5.1.5 Pfizer Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Prostaglandin Analogs Products, Services and Solutions
5.2.4 Novartis Prostaglandin Analogs Revenue (US$ Million) & (2024-2024)
5.2.5 Novartis Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Prostaglandin Analogs Products, Services and Solutions
5.3.4 Merck Prostaglandin Analogs Revenue (US$ Million) & (2024-2024)
5.3.5 Allergan Recent Developments
5.4 Allergan
5.4.1 Allergan Profile
5.4.2 Allergan Main Business
5.4.3 Allergan Prostaglandin Analogs Products, Services and Solutions
5.4.4 Allergan Prostaglandin Analogs Revenue (US$ Million) & (2024-2024)
5.4.5 Allergan Recent Developments
5.5 Newchem S.p.A.
5.5.1 Newchem S.p.A. Profile
5.5.2 Newchem S.p.A. Main Business
5.5.3 Newchem S.p.A. Prostaglandin Analogs Products, Services and Solutions
5.5.4 Newchem S.p.A. Prostaglandin Analogs Revenue (US$ Million) & (2024-2024)
5.5.5 Newchem S.p.A. Recent Developments
6 North America
6.1 North America Prostaglandin Analogs Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prostaglandin Analogs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prostaglandin Analogs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prostaglandin Analogs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prostaglandin Analogs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prostaglandin Analogs Market Dynamics
11.1 Prostaglandin Analogs Industry Trends
11.2 Prostaglandin Analogs Market Drivers
11.3 Prostaglandin Analogs Market Challenges
11.4 Prostaglandin Analogs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Prostaglandin Analogs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Prostaglandin Analogs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Prostaglandin Analogs Market Size Share by Region (2024-2024)
Table 4. Global Prostaglandin Analogs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Prostaglandin Analogs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Prostaglandin Analogs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Prostaglandin Analogs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Prostaglandin Analogs Revenue Market Share by Type (2024-2024)
Table 9. Global Prostaglandin Analogs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Prostaglandin Analogs Revenue Market Share by Type (2024-2034)
Table 11. North America Prostaglandin Analogs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Prostaglandin Analogs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Prostaglandin Analogs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Prostaglandin Analogs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Prostaglandin Analogs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Prostaglandin Analogs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Prostaglandin Analogs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Prostaglandin Analogs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Prostaglandin Analogs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Prostaglandin Analogs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Prostaglandin Analogs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Prostaglandin Analogs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Prostaglandin Analogs Revenue Market Share by Application (2024-2024)
Table 24. Global Prostaglandin Analogs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Prostaglandin Analogs Revenue Market Share by Application (2024-2034)
Table 26. North America Prostaglandin Analogs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Prostaglandin Analogs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Prostaglandin Analogs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Prostaglandin Analogs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Prostaglandin Analogs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Prostaglandin Analogs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Prostaglandin Analogs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Prostaglandin Analogs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Prostaglandin Analogs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Prostaglandin Analogs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Prostaglandin Analogs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Prostaglandin Analogs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostaglandin Analogs as of 2022)
Table 39. Date of Key Players Enter into Prostaglandin Analogs Market
Table 40. Global Prostaglandin Analogs Key Players Headquarters and Area Served
Table 41. Prostaglandin Analogs Product Solution and Service
Table 42. Global Prostaglandin Analogs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer Prostaglandin Analogs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Prostaglandin Analogs Business of Pfizer (2024-2024)
Table 48. Pfizer Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Prostaglandin Analogs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Prostaglandin Analogs Business of Novartis (2024-2024)
Table 53. Novartis Recent Developments
Table 54. Merck Basic Information List
Table 55. Merck Description and Business Overview
Table 56. Merck Prostaglandin Analogs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Prostaglandin Analogs Business of Merck (2024-2024)
Table 58. Merck Recent Developments
Table 59. Allergan Basic Information List
Table 60. Allergan Description and Business Overview
Table 61. Allergan Prostaglandin Analogs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Prostaglandin Analogs Business of Allergan (2024-2024)
Table 63. Allergan Recent Developments
Table 64. Newchem S.p.A. Basic Information List
Table 65. Newchem S.p.A. Description and Business Overview
Table 66. Newchem S.p.A. Prostaglandin Analogs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Prostaglandin Analogs Business of Newchem S.p.A. (2024-2024)
Table 68. Newchem S.p.A. Recent Developments
Table 69. North America Prostaglandin Analogs Market Size by Country (2024-2024) & (US$ Million)
Table 70. North America Prostaglandin Analogs Market Size by Country (2024-2034) & (US$ Million)
Table 71. Europe Prostaglandin Analogs Market Size by Country (2024-2024) & (US$ Million)
Table 72. Europe Prostaglandin Analogs Market Size by Country (2024-2034) & (US$ Million)
Table 73. Asia-Pacific Prostaglandin Analogs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 74. Asia-Pacific Prostaglandin Analogs Market Size by Region (2024-2024) & (US$ Million)
Table 75. Asia-Pacific Prostaglandin Analogs Market Size by Region (2024-2034) & (US$ Million)
Table 76. Asia-Pacific Prostaglandin Analogs Market Share by Region (2024-2024)
Table 77. Asia-Pacific Prostaglandin Analogs Market Share by Region (2024-2034)
Table 78. Latin America Prostaglandin Analogs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 79. Latin America Prostaglandin Analogs Market Size by Country (2024-2024) & (US$ Million)
Table 80. Latin America Prostaglandin Analogs Market Size by Country (2024-2034) & (US$ Million)
Table 81. Middle East & Africa Prostaglandin Analogs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 82. Middle East & Africa Prostaglandin Analogs Market Size by Country (2024-2024) & (US$ Million)
Table 83. Middle East & Africa Prostaglandin Analogs Market Size by Country (2024-2034) & (US$ Million)
Table 84. Prostaglandin Analogs Market Trends
Table 85. Prostaglandin Analogs Market Drivers
Table 86. Prostaglandin Analogs Market Challenges
Table 87. Prostaglandin Analogs Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostaglandin Analogs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Prostaglandin Analogs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Prostaglandin Analogs Market Share by Regions: 2022 VS 2034
Figure 4. Global Prostaglandin Analogs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Prostaglandin Analogs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Prostaglandin Analogs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Prostaglandin Analogs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Prostaglandin Analogs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Prostaglandin Analogs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Xalatan
Figure 11. Global Xalatan Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Travatan
Figure 13. Global Travatan Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Lumigan
Figure 15. Global Lumigan Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Tafluprost
Figure 17. Global Tafluprost Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Prostaglandin Analogs Market Size Share by Type: 2022 & 2034
Figure 19. North America Prostaglandin Analogs Revenue Market Share by Type (2024-2034)
Figure 20. Europe Prostaglandin Analogs Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Prostaglandin Analogs Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Prostaglandin Analogs Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Prostaglandin Analogs Revenue Market Share by Type (2024-2034)
Figure 24. Clinic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Hospital Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Global Prostaglandin Analogs Market Size Share by Application: 2022 & 2034
Figure 28. North America Prostaglandin Analogs Revenue Market Share by Application (2024-2034)
Figure 29. Europe Prostaglandin Analogs Revenue Market Share by Application (2024-2034)
Figure 30. Asia-Pacific Prostaglandin Analogs Revenue Market Share by Application (2024-2034)
Figure 31. Latin America Prostaglandin Analogs Revenue Market Share by Application (2024-2034)
Figure 32. Middle East and Africa Prostaglandin Analogs Revenue Market Share by Application (2024-2034)
Figure 33. Prostaglandin Analogs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 34. Global Top 5 and Top 10 Players Prostaglandin Analogs Market Share in 2022
Figure 35. North America Prostaglandin Analogs Market Share by Country (2024-2034)
Figure 36. U.S. Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 37. Canada Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 38. Germany Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 39. France Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 40. U.K. Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 41. Italy Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 42. Russia Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 43. Nordic Countries Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 44. Asia-Pacific Prostaglandin Analogs Market Share by Region (2024-2034)
Figure 45. China Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 46. Japan Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 47. South Korea Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 48. Southeast Asia Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 49. India Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 50. Australia Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 51. Latin America Prostaglandin Analogs Market Share by Country (2024-2034)
Figure 52. Mexico Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 53. Brazil Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 54. Middle East & Africa Prostaglandin Analogs Market Share by Country (2024-2034)
Figure 55. Turkey Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 56. Saudi Arabia Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 57. UAE Prostaglandin Analogs Market Size (2024-2034) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report